A combination of cyclophosphamide, interleukin-2 allow CD4+ T cells converted to Tregs to control scurfy syndrome.

Authors
Publication date
1 January 2021
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio Istituzionale della Ricerca- Università degli Studi di Foggia

    redirect
    oaioai:fair.unifg.it:11369/434208
    Last time updated on 07/06/2023